Clinical Trial Update: Efficacy and Safety of Mydriatic Microdrops for Retinopathy Of Prematurity Screening [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating efficacy and safety of mydriatic microdrops for retinopathy of prematurity screening has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Retinopathy of Prematurity

Drugs mentioned

• Mydriatic Microdrops

Snippet

Sponsor: Aristotle University Of Thessaloniki | Conditions: Retinopathy of Prematurity | Phase 4 | Status: COMPLETED